Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $44.02 ($1.8M) on 2019-06-19, disclosed to the SEC on 2019-06-21.
Seasonal sale ($1.8M) by Chief Executive Officer — this insider has traded FGEN in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.99 | 1,418 | $62K | 3.6% |
| 2 | $44.02 | 18,400 | $810K | 46.2% |
| 3 | $44.23 | 1,318 | $58K | 3.3% |
| 4 | $44.28 | 16,200 | $717K | 40.9% |
| 5 | $45.22 | 2,200 | $99K | 5.7% |
| 6 | $45.45 | 100 |
| $5K |
| 0.3% |
| Total | $44.20 avg | 39,636 | $1.8M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-07 | $1.5M | — | Filing → |